Computational measurement of tumor immune microenvironment in gastric adenocarcinomas

[1]  Joon-Oh Park,et al.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.

[2]  Nayoung K. D. Kim,et al.  Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability , 2018, ESMO Open.

[3]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[4]  Joon-Oh Park,et al.  Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity , 2017, Oncoimmunology.

[5]  Xinlong Li,et al.  PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis , 2017, PloS one.

[6]  A. Rosato,et al.  Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development , 2017, BioMed research international.

[7]  Cris L. Luengo Hendriks,et al.  The Gold Standard Paradox in Digital Image Analysis: Manual Versus Automated Scoring as Ground Truth. , 2017, Archives of pathology & laboratory medicine.

[8]  Soyeon Ahn,et al.  Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer , 2017, Cancer Immunology, Immunotherapy.

[9]  Adam A. Margolin,et al.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. , 2017, Cell reports.

[10]  Sang-Hoon Ahn,et al.  Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients , 2017, Oncotarget.

[11]  S. Park,et al.  Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability , 2017, Oncotarget.

[12]  A. Ochiai,et al.  Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients , 2017, Gastric Cancer.

[13]  Vahid Azimi,et al.  Quantitative analysis of histological tissue image based on cytological profiles and spatial statistics , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[14]  Jaime Rodriguez-Canales,et al.  Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients , 2016, Clinical Cancer Research.

[15]  G. Freeman,et al.  Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers , 2016, Oncotarget.

[16]  Ju-Seog Lee,et al.  Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration , 2016, Clinical Cancer Research.

[17]  F. Hirsch,et al.  Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe? , 2016, Archives of pathology & laboratory medicine.

[18]  Antoni Ribas,et al.  Classifying Cancers Based on T-cell Infiltration and PD-L1. , 2015, Cancer research.

[19]  S. Klempner,et al.  Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations. , 2015, Journal of gastrointestinal oncology.

[20]  P. Romero,et al.  C O M M E N T a R Y Open Access , 2022 .

[21]  G. Hu,et al.  New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.

[22]  Johann A. Gagnon-Bartsch,et al.  Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas , 2014, Gut.

[23]  Insuk Sohn,et al.  Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery , 2014, PloS one.

[24]  Alison P. Klein,et al.  Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape , 2012, Science Translational Medicine.

[25]  Aldo Badano,et al.  Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy. , 2011, Archives of pathology & laboratory medicine.

[26]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[27]  Martial Guillaud,et al.  Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. , 2005, Gynecologic oncology.

[28]  A. Ruifrok,et al.  Comparison of Quantification of Histochemical Staining By Hue-Saturation-Intensity (HSI) Transformation and Color-Deconvolution , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[29]  Berthold Lausen,et al.  Maximally selected rank statistics , 1992 .